Evaluate the Efficacy and Safety of Radiotherapy Combined With Ripretinib in the Treatment of Unresectable Advanced GIST

NCT06507683 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Gastrointestinal Stromal Tumors

Interventions

RADIATION: simultaneous integrated boost intensity-modulated radiation therapy combined with ripretinib

Sponsor

First Affiliated Hospital of Chongqing Medical University

Collaborators

[object Object]